Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.

about

Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.

P2860

Q35664106-1F28D370-9562-4E32-AA9E-249F4CD9592D Q39365643-D2E9F45E-613F-4AA9-B2AA-19B6F0200F85

P2860

Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.

Item

http://www.wikidata.org/entity/Q35917368

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Therapeutic options for human ...... herpesvirus-related disorders.

@ast

Therapeutic options for human ...... herpesvirus-related disorders.

@en

type

Item

label

Therapeutic options for human ...... herpesvirus-related disorders.

@ast

Therapeutic options for human ...... herpesvirus-related disorders.

@en

prefLabel

Therapeutic options for human ...... herpesvirus-related disorders.

@ast

Therapeutic options for human ...... herpesvirus-related disorders.

@en

P1476

Therapeutic options for human ...... herpesvirus-related disorders.

@en

P2093

Giovanna Tosato

http://www.w3.org/2001/XMLSchema#string

Yoshiyasu Aoki

http://www.w3.org/2001/XMLSchema#string

P2860

AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies

Validating survivin as a cancer therapeutic target

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy.

Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma.

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy.

High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease.

Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.

Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group.

P304

213-225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.2.2.213

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15482187

http://www.w3.org/2001/XMLSchema#string

Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.

about

P2860

P2860

Therapeutic options for human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus-related disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698